TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.00$ +0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement XLO
Line item 2019 2020 2021 2022 2023 2024 2025
0.00 0.00 0.00 0.00 0.00 1.66 5.24
8.21 28.47 3.74 0.07 0.97 0.43 0.18
-8.21 -28.47 -3.74 -0.07 -0.97 1.66 5.05
487.62 1,173.65 127.83 2.16 26.55 10.78 6.70
163.19 284.74 59.57 1.09 13.75 6.48 3.55
642.60 1,429.92 187.40 3.25 40.29 17.51 10.07
-650.81 -1,458.39 -187.40 -3.25 -40.29 -15.85 -5.02
0.00 16.04 1.89 0.03 0.07 0.03 –
-592.11 -1,475.92 -189.29 -3.22 -38.90 -15.24 -4.19
2.33 22.95 -3.74 -0.03 -0.47 – –
-592.11 -1,475.92 -185.54 -3.19 -38.90 -15.24 -4.19
-583.90 -1,431.42 -183.66 -3.19 -37.93 -15.18 -4.01

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?